This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2007 by Eulji General Hospital.
Recruitment status was:  Recruiting
Information provided by:
Eulji General Hospital Identifier:
First received: September 19, 2007
Last updated: NA
Last verified: September 2007
History: No changes posted
The purpose of this study is to determine whether on-line hemodiafiltration ameliorate the endothelial dysfunction compared with the low flux hemodialysis in end stage renal disease patients on maintenance hemodialysis.

Condition Intervention Phase
End Stage Renal Disease Hemodialysis Procedure: On-line hemodiafiltration Procedure: Low flux hemodialysis Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of On-Line Hemodiafiltration(HDF) on Endothelial Dysfunction in Chronic Hemodialysis Patients

Resource links provided by NLM:

Further study details as provided by Eulji General Hospital:

Primary Outcome Measures:
  • endothelial dysfunction measured by flow-mediated vasodilation [ Time Frame: 4 months ]

Estimated Enrollment: 20
Study Start Date: April 2007
Estimated Study Completion Date: March 2008
Arms Assigned Interventions
Experimental: O Procedure: On-line hemodiafiltration
Active Comparator: L Procedure: Low flux hemodialysis

Detailed Description:
  1. On-line hemodiafiltration(OL-HDF) is a technique that combines diffusion with convection in which the large substitution fluid is produced directly from the dialysate. It offers many advantages aside from its safe inflammatory profile, which is attributable to the use of ultrapure dialysate and highly biocompatible dialysis membranes. Due to an improved convective clearance, significantly increased removal of large or protein-bound uremic retention solutes can be achieved, with a potential benefit on cardiovascular morbidity and mortality.
  2. Endothelial dysfunction, almost universal in end stage renal disease, is important risk factor for cardiovascular events, and can be evaluated by brachial artery endothelium-dependent vasodilation (flow-mediated dilation) to reactive hyperemia following 5 min of forearm ischemia.
  3. The stable HD patients will receive 8-week treatment on OL-HDF or conventional low flux HD and then crossed over to opposite treatment arm. The FMD will be measured by one sonographer, and at the same time whole blood and serum will be sampled and stored for further analysis. The timepoint for measurement is 4-week interval after baseline evaluation.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • end stage renal disease on maintenance hemodialysis for more than 3 months

Exclusion Criteria:

  • diagnosis of active cardiovascular diseases in 6 months
  • elevation of liver enzymes over two fold of upper normal limit in 3 months
  • admission for acute infection in 3 months
  • untreatable stenosis of vascular access
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00532597

Contact: Young-Hwan Hwang, M.D. 82-2-970-8457
Contact: Su-Ah Sung, M.D., PhD. 82-2-970-8205

Korea, Republic of
Eulji General Hospital Recruiting
Seoul, Korea, Republic of
Contact: Young-Hwan Hwang, M.D.    82-2-970-8457   
Contact: Su-Ah Sung, M.D.,PhD.    82-2-970-8205   
Sponsors and Collaborators
Eulji General Hospital
Study Chair: SuAh Sung, M.D.,PhD. Department of Internal Medicine, College of Medicine, Eulji University
  More Information Identifier: NCT00532597     History of Changes
Other Study ID Numbers: EMCIRB 07-01
Study First Received: September 19, 2007
Last Updated: September 19, 2007

Keywords provided by Eulji General Hospital:
Vascular Endothelium-Dependent Relaxation

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases processed this record on September 21, 2017